Author
Piotr Pawłowski
Other affiliations: Roswell Park Cancer Institute, GSI Helmholtz Centre for Heavy Ion Research, Centre national de la recherche scientifique
Bio: Piotr Pawłowski is an academic researcher from Polish Academy of Sciences. The author has contributed to research in topics: Neutron & Nucleon. The author has an hindex of 21, co-authored 134 publications receiving 1656 citations. Previous affiliations of Piotr Pawłowski include Roswell Park Cancer Institute & GSI Helmholtz Centre for Heavy Ion Research.
Topics: Neutron, Nucleon, Charged particle, Proton, Isospin
Papers published on a yearly basis
Papers
More filters
University of Liverpool1, Jagiellonian University2, National Autonomous University of Mexico3, King Abdulaziz City for Science and Technology4, King Saud University5, University of Messina6, Technische Universität Darmstadt7, GSI Helmholtz Centre for Heavy Ion Research8, University of Santiago de Compostela9, Polish Academy of Sciences10, Texas A&M University11, Michigan State University12, University of Catania13, Western Michigan University14, University of Milan15, Polytechnic University of Turin16, Hungarian Academy of Sciences17, Daresbury Laboratory18, Huzhou University19, University of Naples Federico II20, University of Bordeaux21, Washington University in St. Louis22, Université Paris-Saclay23, Slovak Academy of Sciences24, Ludwig Maximilian University of Munich25
TL;DR: In this article, the authors measured directed and elliptic flows of neutrons and light charged particles for the reaction 197Au+197Au at 400 MeV/nucleon incident energy within the ASY-EOS experimental campaign at the GSI laboratory.
Abstract: Directed and elliptic flows of neutrons and light charged particles were measured for the reaction 197Au+197Au at 400 MeV/nucleon incident energy within the ASY-EOS experimental campaign at the GSI laboratory. The detection system consisted of the Large Area Neutron Detector LAND, combined with parts of the CHIMERA multidetector, of the ALADIN Time-of-flight Wall, and of the Washington-University Microball detector. The latter three arrays were used for the event characterization and reaction-plane reconstruction. In addition, an array of triple telescopes, KRATTA, was used for complementary measurements of the isotopic composition and flows of light charged particles. From the comparison of the elliptic flow ratio of neutrons with respect to charged particles with UrQMD predictions, a value \gamma = 0.72 \pm 0.19 is obtained for the power-law coefficient describing the density dependence of the potential part in the parametrization of the symmetry energy. It represents a new and more stringent constraint for the regime of supra-saturation density and confirms, with a considerably smaller uncertainty, the moderately soft to linear density dependence deduced from the earlier FOPI-LAND data. The densities probed are shown to reach beyond twice saturation.
193 citations
TL;DR: In this article, the elliptic flow ratio of neutrons with respect to protons or light complex particles in reactions of neutron-rich systems at relativistic energies is proposed as an observable sensitive to the strength of the symmetry term in the equation of state at supra-normal densities.
179 citations
TL;DR: In this paper, a correlation technique for the relative velocity between light charged particles (LCP) and fragments was used to extract the multiplicities and average kinetic energy of secondary evaporated LCP.
Abstract: Characteristics of the primary fragments produced in central collisions of ${}^{129}\mathrm{Xe}{+}^{\mathrm{nat}}\mathrm{Sn}$ from 32 to 50 A MeV have been obtained. By using the correlation technique for the relative velocity between light charged particles (LCP) and fragments, we were able to extract the multiplicities and average kinetic energy of secondary evaporated LCP. We then reconstructed the size and excitation energy of the primary fragments. For each bombarding energy a constant value of the excitation energy per nucleon over the whole range of fragment charge has been found. This value saturates at 3A MeV for beam energies 39A MeV and above. The corresponding secondary evaporated LCP represent less than 40% of all produced particles and decreases down to 23% for 50A MeV. The experimental characteristics of the primary fragments are compared to the predictions of statistical multifragmentation model (SMM) calculations. Reasonable agreement between the data and the calculation has been found for any given incident energy. However SMM fails to reproduce the trend of the excitation function of the primary fragment excitation energy and the amount of secondary evaporated LCP's.
79 citations
TL;DR: The N/Z dependence of projectile fragmentation at relativistic energies has been studied with the ALADIN forward spectrometer at the GSI Schwerionen Synchrotron (SIS).
Abstract: The N/Z dependence of projectile fragmentation at relativistic energies has been studied with the ALADIN forward spectrometer at the GSI Schwerionen Synchrotron (SIS). Stable and radioactive Sn and La beams with an incident energy of 600 MeV per nucleon have been used in order to explore a wide range of isotopic compositions. For the interpretation of the data, calculations with the statistical multifragmentation model for a properly chosen ensemble of excited sources were performed. The parameters of the ensemble, representing the variety of excited spectator nuclei expected in a participant-spectator scenario, are determined empirically by searching for an optimum reproduction of the measured fragment-charge distributions and correlations. An overall very good agreement is obtained. The possible modification of the liquid-drop parameters of the fragment description in the hot freeze-out environment is studied, and a significant reduction of the symmetry-term coefficient is found necessary to reproduce the mean neutron-to-proton ratios /Z and the isoscaling parameters of Z{<=}10 fragments. The calculations are, furthermore, used to address open questions regarding the modification of the surface-term coefficient at freeze-out, the N/Z dependence of the nuclear caloric curve, and the isotopic evolution of the spectator system between its formation during the initial cascade stage ofmore » the reaction and its subsequent breakup.« less
74 citations
TL;DR: In this paper, the authors measured the spectra of charged pions produced by colliding rare isotope tin (Sn) beams with isotopically enriched Sn targets and deduced the slope of the symmetry energy to be 42
Abstract: Many neutron star properties, such as the proton fraction, reflect the symmetry energy contributions to the equation of state that dominate when neutron and proton densities differ strongly. To constrain these contributions at suprasaturation densities, we measure the spectra of charged pions produced by colliding rare isotope tin (Sn) beams with isotopically enriched Sn targets. Using ratios of the charged pion spectra measured at high transverse momenta, we deduce the slope of the symmetry energy to be 42
67 citations
Cited by
More filters
01 Jan 2000
3,536 citations
University of Lausanne1, University of Zurich2, Pierre-and-Marie-Curie University3, Tel Aviv Sourasky Medical Center4, University of California, San Diego5, Tel Aviv University6, Geisinger Health System7, Tufts Medical Center8, University of Pittsburgh9, Baylor University Medical Center10, Cleveland Clinic11, Washington University in St. Louis12, University of Illinois at Chicago13, University of Southern California14, Barnes-Jewish Hospital15, Maine Medical Center16, Houston Methodist Hospital17, Lyon College18
TL;DR: In this interim analysis of 315 patients with glioblastoma who had completed standard chemoradiation therapy, adding TTFields to maintenance temozolomide chemotherapy significantly prolonged progression-free and overall survival.
Abstract: Importance Glioblastoma is the most devastating primary malignancy of the central nervous system in adults. Most patients die within 1 to 2 years of diagnosis. Tumor-treating fields (TTFields) are a locoregionally delivered antimitotic treatment that interferes with cell division and organelle assembly. Objective To evaluate the efficacy and safety of TTFields used in combination with temozolomide maintenance treatment after chemoradiation therapy for patients with glioblastoma. Design, Setting, and Participants After completion of chemoradiotherapy, patients with glioblastoma were randomized (2:1) to receive maintenance treatment with either TTFields plus temozolomide (n = 466) or temozolomide alone (n = 229) (median time from diagnosis to randomization, 3.8 months in both groups). The study enrolled 695 of the planned 700 patients between July 2009 and November 2014 at 83 centers in the United States, Canada, Europe, Israel, and South Korea. The trial was terminated based on the results of this planned interim analysis. Interventions Treatment with TTFields was delivered continuously (>18 hours/day) via 4 transducer arrays placed on the shaved scalp and connected to a portable medical device. Temozolomide (150-200 mg/m 2 /d) was given for 5 days of each 28-day cycle. Main Outcomes and Measures The primary end point was progression-free survival in the intent-to-treat population (significance threshold of .01) with overall survival in the per-protocol population (n = 280) as a powered secondary end point (significance threshold of .006). This prespecified interim analysis was to be conducted on the first 315 patients after at least 18 months of follow-up. Results The interim analysis included 210 patients randomized to TTFields plus temozolomide and 105 randomized to temozolomide alone, and was conducted at a median follow-up of 38 months (range, 18-60 months). Median progression-free survival in the intent-to-treat population was 7.1 months (95% CI, 5.9-8.2 months) in the TTFields plus temozolomide group and 4.0 months (95% CI, 3.3-5.2 months) in the temozolomide alone group (hazard ratio [HR], 0.62 [98.7% CI, 0.43-0.89]; P = .001). Median overall survival in the per-protocol population was 20.5 months (95% CI, 16.7-25.0 months) in the TTFields plus temozolomide group (n = 196) and 15.6 months (95% CI, 13.3-19.1 months) in the temozolomide alone group (n = 84) (HR, 0.64 [99.4% CI, 0.42-0.98]; P = .004). Conclusions and Relevance In this interim analysis of 315 patients with glioblastoma who had completed standard chemoradiation therapy, adding TTFields to maintenance temozolomide chemotherapy significantly prolonged progression-free and overall survival. Trial Registration clinicaltrials.gov Identifier:NCT00916409
926 citations
TL;DR: In this paper, Belitz et al. presented a survey of the state-of-the-art in condensed-matter physics, focusing on the following papers: Condensed Matter Physics (Theoretical) J. IGNACIO CIRAC, Max-Planck-Institut für Quantenoptik Quantum Information RAYMOND E. GOLDSTEIN, University of Cambridge Biological Physics ARTHUR F. HEBARD and DAVID D. KAMIEN.
Abstract: Associate DIETRICH BELITZ, University of Oregon Editors: Condensed Matter Physics (Theoretical) J. IGNACIO CIRAC, Max-Planck-Institut für Quantenoptik Quantum Information RAYMOND E. GOLDSTEIN, University of Cambridge Biological Physics ARTHUR F. HEBARD, University of Florida Condensed Matter Physics (Experimental) RANDALL D. KAMIEN, University of Pennsylvania Soft Condensed Matter DANIEL KLEPPNER, Massachusetts Institute of Technology Atomic, Molecular, and Optical Physics (Experimental) PAUL G. LANGACKER, Institute for Advanced Study, Princeton University Particle Physics (Theoretical) VERA LÜTH, Stanford University Particle Physics (Experimental) DAVID D. MEYERHOFER, University of Rochester Physics of Plasmas and Matter at High-Energy Density WITOLD NAZAREWICZ, University of Tennessee, Oak Ridge National Laboratory Nuclear Physics JOHN H. SCHWARZ, California Institute of Technology Mathematical Physics FRIEDRICH-KARL THIELEMANN, Universität Basel Astrophysics Senior Assistant Editor: DEBBIE BRODBAR, APS Editorial Office American Physical Society
774 citations
Journal Article•
[...]
TL;DR: It’s time to get used to the idea that there is no such thing as a safe place to die.
Abstract: 它是美国国立医学图书馆（NLM）生产的国际性生物医学文献联机书目数据库，是美国国立医学图书馆MEDLARS系统30多个数据库中最大的一个数据库，是世界上最著名的生物医学数据库之一。其内容相当于3种印刷本检索刊物：《医学索引》（index medicus，IM）、《牙科文献索引》、《国际护理学索引》，收录了1966年以来的70多个国家4300多种期刊的题录和文摘共1100万条记录，
678 citations